Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-26 @ 4:02 AM
Study NCT ID:
NCT04452318
Status:
COMPLETED
Last Update Posted:
2023-05-15
First Post:
2020-06-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-04
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-26
First Submit QC Date:
None
Study First Post Date:
2020-06-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-29
Results First Submit QC Date:
None
Results First Post Date:
2023-05-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-20
Last Update Post Date:
2023-05-15
Last Update Post Date Type:
ACTUAL